The COVID-19 pandemic and the expectation of future pandemic threats have generated a
global dialogue on strengthening pandemic preparedness and response (PPR). Thus far …

Objective: National centralized drug procurement organized by the Chinese government
currently represents the largest group purchasing organization worldwide, to establish a …

Background: Improving drug accessibility and rational drug use are major challenges for
China's healthcare reform. In 2018, the Chinese government introduced a novel nationwide …

Economics and innovation scholars have long recognized the potential of public
procurement to trigger innovation. To what extent has this potential been realized so far …

This paper examines the determinants of public procurement prices using comprehensive
data on pharmaceutical purchases by the public sector in Chile. We first document sizable …

Objectives Optimizing the pharmaceutical industrial structure is the key mission of China's
healthcare reform. From the industrial structure perspective, this study empirically evaluated …

This paper studies the impact of the first joint licensing platform for patented drugs, the
Medicines Patent Pool, on global drug diffusion and innovation. The pool allows generic …

Noncommunicable diseases (NCDs) are the leading cause of death in the world, and 80%
of all NCD deaths occur in low-and middle-income countries (LMICs). The COVID-19 …

This note discusses, through selected country case studies, how digital health records and
telemedicine can improve delivery quality, access to underserved populations, and resource …

Understanding the cost and benefit of global public health institutions is important but
challenging. This study provides a cost-benefit analysis of the first public health-oriented …